← back to search

Steven Ketchum

Mount Sinai Hospital · US
Area of research
Surgery · Nutrition and Dietetics
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Fatty Acid Research and Health, Diet and metabolism studies, and Diabetes, Cardiovascular Risks, and Lipoproteins.
h-index
14
citations
4,230
works
55
NIH funding
primary concept
email

Recent publications

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial
European Heart Journal 2024cited by 27position: middledoi
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT
Journal of the American Heart Association 2023cited by 25position: middledoi
Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-IT
European Heart Journal 2023cited by 8position: middledoi
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction
Journal of the American College of Cardiology 2022cited by 57position: middledoi
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT
Journal of the American College of Cardiology 2021cited by 34position: middledoi
Abstract 57: Reduction in Ischemic Stroke With Icosapent Ethyl - Insights From REDUCE-IT
Stroke 2021cited by 3position: middledoi
Reduction in Revascularization With Icosapent Ethyl
Circulation 2020cited by 57position: middledoi
Effects of Icosapent Ethyl on Total Ischemic Events
Journal of the American College of Cardiology 2019cited by 256position: middledoi
REDUCE-IT USA
Circulation 2019cited by 133position: middledoi
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
New England Journal of Medicine 2018cited by 3,206position: middledoi
Rationale and design of <scp>REDUCE‐IT</scp>: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
Clinical Cardiology 2017cited by 182position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Terry A. Jacobson · Emory University11 papers (2017–2024)Philippe Gabríel Steg · Mount Sinai Hospital11 papers (2017–2024)Deepak L. Bhatt · Technische Universität Dresden11 papers (2017–2024)Michael Miller · University of Colorado Anschutz Medical Campus11 papers (2017–2024)Eliot A. Brinton · Icahn School of Medicine at Mount Sinai11 papers (2017–2024)Christie M. Ballantyne · New York University11 papers (2017–2024) · 10 papers (2017–2024)Jean‐Claude Tardif · United States Nuclear Regulatory Commission10 papers (2017–2024)Rebecca A. Juliano · Rapt Therapeutics (United States)9 papers (2017–2023)Lixia Jiao · Berry Oncology (China)8 papers (2018–2024)Craig Granowitz · Opexa Therapeutics (United States)7 papers (2018–2022)C. Michael Gibson · CytoSorbents (United States)4 papers (2019–2022)Robert P. Giugliano · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo4 papers (2019–2022)Matthew J. Budoff · Phoenix (United States)3 papers (2019–2021)Mina K. Chung · Broad Institute2 papers (2019–2023)Prakriti Gaba · Harvard University2 papers (2021–2022)Armando Lira Pineda · Amgen (United States)2 papers (2023–2024)John Gregson · University of London2 papers (2019–2021)Brian Olshansky · Covenant Medical Center2 papers (2019–2023)Duane S. Pinto · University of Birmingham2 papers (2020–2021)